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NATIONAL INSTITUTES OF HEALTH 
WORKSHOP STATEMENT 
Reproductive Genetic Testing: 
Impact on Women 
Reproductive genetic testing, counseling, and other 
genetic services can be valuable components in the 
reproductive health care of women and their families; 
they can also have negative effects on individuals, on 
families, and on communities. These services have the 
potential to increase knowledge about possible preg-
nancy outcomes that may occur if a woman decides 
to reproduce; provide reassurance during pregnancy; 
enhance the developing relationship between the 
woman, her expected child, and others; allow a woman 
an opportunity to choose whether to continue a preg-
nancy in which the expected child has a birth defect 
or a genetic disorder; and, if continuing, both facilitate 
prenatal or early infant therapy for the expected child, 
when possible, and prepare the family for bearing and 
rearing a child with a disability. Conversely, these ser-
vices have the potential to increase anxiety; place ex-
cessive responsibility, blame, and guilt on a woman 
for her pregnancy outcome; interfere with mother-
infant bonding; and disrupt relationships between a 
woman, family members, and her community. 
The challenge is to provide each woman with an 
opportunity to have access to desired genetic services, 
in a way that will improve her control over the circum-
stances of her reproductive life, her pregnancies, 
childbearing, and parenting, within a framework that 
is sensitive to her needs and values and that minimizes 
the potential for coercion. The value that women and 
their families place on these services depends heavily 
on a mixture of psychological and ethno-cultural in-
fluences, religious and moral values, and legal and 
economic constraints that are unique to each woman. 
In addition, it may be influenced by a woman's percep-
tions about and past experience with people with dis-
abilities. As a consequence, women in different cir-
cumstances may weigh the merits of reproductive 
genetic services quite differently. 
These complex individual differences among women 
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challenge efforts to evaluate the safety and efficacy of 
reproductive genetic services. To reflect the function 
of genetic services in reproductive health care, evalua-
tion criteria must be client centered. That is, beyond 
assessment of the biological safety and technical relia-
bility of reproductive genetic services, there should be 
assessment to determine whether they fulfill the roles 
that their clients define for them. Women may be inter-
ested in knowing to what extent reproductive genetic 
services can reassure, facilitate planning, and improve 
informed decision making, as well as how they can 
limit potentially offsetting costs such as the risk for 
coercion, increased anxiety, and compromise of their 
own values. Further, it may be important to determine 
to what extent reproductive genetic services can be 
modulated to respect the n~eds and interests of individ-
ual women and their families. Research designed tO 
evaluate reproductive genetic services in these terms is 
urgently needed. 
This understanding of reproductive genetic services 
has several important implications that should be con-
sidered in the development of a future research agenda 
in this area. 
1. Reproductive genetic services should not be used 
to pursue "eugenic" goals but should be aimed at 
increasing individuals' control over their own repro-
ductive lives. Therefore, new strategies need to be de-
veloped to evaluate the success of such services. Re-
productive genetic services must ultimately serve 
personal-not public-interests, in improving the 
overall reproductive lives of women. Whatever soci-
etal gains might be realized through the eugenic use of 
reproductive genetic services should be heavily om-
weighed by the personal needs of women and their 
families. The ideals of self-determination in family 
matters and respect for individual differences, ideals 
that lie behind the client-centered view of reproductive 
genetic services, are jeopardized whenever the primary 
goal of these services becomes the prevention of the 
birth of individuals with a disorder or a disability. 
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Such a goal has the potential to constrain the choices 
available to women and to further stigmatize those 
individuals affected by a particular disorder or disabil-
ity. To the extent that voluntary reproductive genetic 
services are evaluated even indirectly in eugenic terms, 
societal pressures have the potential to threaten the 
important interests and desires of individual women 
and their families. 
2. Reproductive genetic services should be meticu-
lously voluntary. Since the primary goal of reproduc-
tive genetic services should be to enhance personal 
reproductive decisions, such testing should not be 
swept in with other "routine" or "universal" reproduc-
tive interventions, unless informed consent or refusal 
can be assured. Assisting women to give a fully in-
formed consent or refusal to genetics education, test-
ing, and counseling services is at the heart of these 
services. Whether reproductive genetic services are 
provided by genetics professionals or other health-care 
professionals, it is vital that these services be provided 
in a non judgmental and noncoercive manner and that 
the testing be carried out only after adequate educa-
tion about their benefits and risks, including those 
beyond biology. The success of reproductive genetic 
services depends on their ability to effectively em-
power people to make knowledgeable and informed 
decisions. As a result, methods to evaluate the success 
or failure of these services should be devised with this 
goal in mind. 
3. Reproductive genetic services should be value 
sensitive. Providers of reproductive genetic services 
should be particularly sensitive to individual differ-
ences and similarities- including ethno-cultural dif-
ferences and similarities and various constellations of 
beliefs, value commitments, and relationships-and 
should adapt their services accordingly. In particular, 
providers of reproductive genetic services need to be 
aware of their own value system, which has developed 
within the context and culture of the biomedical sci-
ences, and to be aware of the language, undertones, 
assumptions, and values hidden within their own pro-
fessions. Training of professionals who will provide 
these services should include special emphasis on in-
fluences of psychological, sociodemographic, reli-
gious and moral values, and ethno-cultural diversity 
in women's needs and interests regarding reproductive 
genetic testing services. The true impact that the pro-
viders' gender, race, ethnicity·, class, and educational 
discipline have on how services are provided must be 
evaluated. 
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4. Standards of care for reproductive genetic ser-
vices should emphasize genetic information, educa-
tion, and counseling rather than testing procedures 
alone. To the extent that reproductive genetic services 
are designed to facilitate personal reproductive plan-
ning, providers of reproductive genetic testing and 
counseling should tailor their services to meet the 
needs and interests of individual women from the be-
ginning. Extreme efforts should be made to assure 
that the content of information shared regarding the 
disorders for which testing is carried out is comprehen-
sive, accurate, and provided in an unbiased manner, 
so that a true picture of what life with such a disability 
may be like is presented. 
Evaluation measures to determine when women 
know enough to have these interests met could serve 
to establish professional standards of care that do not 
drive providers to encourage testing when it is not 
desired. Conversely, sometimes providers do not offer 
reproductive genetic testing unless a woman knows 
enough to ask for these services. Further evaluation 
must be done to determine the balance which must be 
reached in educating women so that they have enough 
information about these services but do not feel pres-
sure to utilize them when they are not desired. 
5. Social, legal, and economic constraints on repro-
ductive genetic services should be removed. Govern-
ment and institutional policies have continued to in-
fluence legal and fiscal rules that limit the reproductive 
genetic testing choices that women have available to 
them. Research is needed to clarify such constraints 
and how they affect the choices and availability of 
services. Research is also needed to develop and test 
alternative models for delivery that would improve 
access and reduce barriers to repwductive genetic ser-
vices for those women who desire them. 
6. Increasing attention focused on the development 
and utilization of reproductive genetic testing services 
may further stigmatize individuals affected by a partic-
ular disorder or disability. The values that some place 
on health and disabilities, what people may be told 
about disabilities, and even the use of certain language 
to describe the benefits of reproductive genetic testing 
have the potential to devalue the worth that individu-
als with disabilities have in society. Both increased 
sensitivity to these issues and improved communica-
tion between the biomedical and the disability com-
munities are urgently needed in order for the true im-
pact of these developing technologies to become 
known. Individuals with disabilities, who have a vari-
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ety of information, experiences, and views to share, 
must be involved in the development and implementa-
tion of further research to be carried out in this area. 
In summary, there are a number of ways that repro-
ductive genetic services may continue to be, in many 
cases, less than ideal. This system of care will fail not 
only if providers are not informed about and sensitive 
to the importance of individual differences among 
women, but also if women themselves do not under-
stand the complexity of making decisions about 
whether to utilize these services within the context of 
their own needs. The future of reproductive genetic 
testing within the context of reproductive health care 
of women and their families depends on research activ-
ities that are aimed at a better understanding of how 
best to address these challenges. 
Note added in proo}.- This statement and the en-
tire proceedings of this workshop will be published 
in the December 1992 issue of Fetal Diagnosis and 
Therapy. 
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Workshop Participants 
Members of the Workshop were as follows: co-
chairs-Elizabeth Thomson, R.N., M.S., University 
of Iowa, and Karen Rothenberg, J.D., M.P.A., Uni-
versity of Maryland School of Law; Panel members-
Ruth Schwanz Cowan, Ph.D., State University of 
New York at Stony Brook; John Meany, Ph.D., Coun-
cil of Regional Networks for Genetic Services; Jessica 
Davis, M.D., Cornell University; Ellen Wright Clay-
ton, M.D., J.D., Vanderbilt University; Barbara Katz 
Rothman, Ph.D., The City University of New York; 
Deborah Kaplan, J.D., World Institute on Disability; 
Mark Evans, M.D., Wayne State University School of 
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Medicine; Dorothy Wertz, Ph.D., Shriver Center for 
Mental Retardation; Rayna Rapp, Ph.D., New School 
of Social Research; Nancy Press, Ph.D., University of 
California, Los Angeles; Mary Ann Coffman, M.S., 
Oklahoma State Department of Health; Laurie Nsiah-
Jefferson, M.P.H., New Jersey Department of Health; 
Ruth Faden, Ph.D., Johns Hopkins University; Patri-
cia King, J.D., Georgetown University Law Center; 
Alta Charo, J.D., University of Wisconsin; Adrienne 
Asch, A.C.S.W., C.S.W.; Rita Beck Black, D.S.W., 
Columbia University; Sandra Tunis, Ph.D., Univer-
sity of California, San Francisco; Abby Lippman, 
Ph.D., McGill University; Bartha Knoppers, Ph.D., 
University of Montreal; Vict.Jr Penc'•aszadeh, M.D., 
Beth Israel Medical Center; Suza1~ne Braga, M.D., 
Medizinische Universitats-Kinderklinik; Neil A. 
Holtzman, M.D., The Johns Hopkins Medical Insti-
tutions; Ann C. M. Smith, M.A.; Elena Gates, M.D., 
University of California, San Francisco; and Frederic 
Frigoletto, M.D., Harvard Medical School. 
Workshop moderators were as follows: Jane Fullar-
ton, M.P.A., Institute of Medicine, National Acad-
emy of Sciences; Robyn Nishimi, Ph.D., Office of 
Technology Assessment; Nancy Wexler, Ph.D., Co-
lumbia University and Hereditary Disease Founda-
tion; John Fletcher, Ph.D., University of Virginia; 
Anita Allen, J.D., Ph.D., Georgetown University 
Law Center; Robin J. R. Blatt, M.P.H., R.N., Massa-
chusetts Department of Public Health; Maurice J. Ma-
honey, M.D., Yale University School of Medicine; 
and Elsa Gomez, Ph.D., Pan American World Health 
Organization. 
Cosponsors were the National Institute of Child 
Health and Human Development, National Center 
for Human Genome Research, National Center for 
Nursing Research, and the Office of Research on 
Women's Health. 
